SG/CALL/ABBOTT LABORATORIES/130/0.1/20.09.24 Share Price

Warrant

DE000SQ4E724

Delayed Deutsche Boerse AG 06:10:30 15/05/2024 pm IST
0.027 EUR -10.00% Intraday chart for SG/CALL/ABBOTT LABORATORIES/130/0.1/20.09.24
Current month-52.38%
1 month-80.00%
Date Price Change
15/24/15 0.027 -10.00%
14/24/14 0.03 -23.08%
13/24/13 0.039 -4.88%
10/24/10 0.041 +10.81%
09/24/09 0.037 -5.13%

Delayed Quote Deutsche Boerse AG

Last update May 15, 2024 at 06:10 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SQ4E72
ISINDE000SQ4E724
Date issued 16/11/2022
Strike 130 $
Maturity 20/09/2024 (128 Days)
Parity 10 : 1
Emission price 0.74
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.1
Lowest since issue 0.024
Spread 0.019
Spread %41.30%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104 USD
Average target price
126.1 USD
Spread / Average Target
+21.28%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW